Our Network
EndPoints is made up of centers of excellence in clinical research, with a presence across various regions of Latin America. Each center contributes local expertise, robust infrastructure, and a shared commitment to public health, ethics, and operational quality.
Our Network
EndPoints is made up of centers of excellence in clinical research, with a presence across various regions of Latin America. Each center contributes local expertise, robust infrastructure, and a shared commitment to public health, ethics, and operational quality.
CEVAXIN
Location: Panama City
Specialties: Vaccines, infectious diseases, respiratory, HIV, HPV, pneumococcus, RSV
Key infrastructure:
- Medical offices, in-house pharmacy, and laboratory
- Monitoring room and informed consent facilities
- Real-time management platform
Completed studies:
- 60+ clinical trials
- 20,000+ participants
- Pediatric, adult, and pregnant populations
- Contributions to 10+ vaccines now approved
CEIP
Location: Cali, Colombia
Specialties: Vaccines, infectious diseases, maternal-child health, community-based studies
Key infrastructure:
- 14 consultation rooms, pharmacy, laboratory, and call center
- Resuscitation room and auditorium
- 85 °C freezers, cold storage units, and redundant connectivity systems
Completed studies:
- 50+ clinical trials
- 28,000+ enrolled participants
- Contributions to 15+ approved vaccines
CECLISA
Location: Guatemala City
Specialties: Vaccines, pediatrics, respiratory diseases, gastroenterology
Key infrastructure:
- Pediatric and adult consultation rooms
- Laboratory with sample processing and PBMC capabilities
- Procedure and observation rooms
- 70 °C freezers and validated cold chain
Completed studies:
- 20+ clinical trials
- Participation in phase II and III studies, including pediatric and COVID-19 vaccine trials
PSN
Location: Bogotá (Usaquén), Colombia
Specialties: Vaccines, gastroenterology, respiratory health
Key infrastructure:
- Private IPS with over 30 years of clinical experience
- Research center approved by INVIMA
- Electronic medical records and fast-track enrollment capability
Completed studies:
- 6+ clinical trials since 2021
- Record-setting enrollment in COVID-19 and RSV studies
CEVAXIN
Location: Panama City
Specialties: Vaccines, infectious diseases, respiratory, HIV, HPV, pneumococcus, RSV
Key infrastructure:
- Medical offices, in-house pharmacy, and laboratory
- Monitoring room and informed consent facilities
- Real-time management platform
Completed studies:
- 60+ clinical trials
- 20,000+ participants
- Pediatric, adult, and pregnant populations
- Contributions to 10+ vaccines now approved
CEIP
Location: Cali, Colombia
Specialties: Vaccines, infectious diseases, maternal-child health, community-based studies
Key infrastructure:
- 14 consultation rooms, pharmacy, laboratory, and call center
- Resuscitation room and auditorium
- 85 °C freezers, cold storage units, and redundant connectivity systems
Completed studies:
- 50+ clinical trials
- 28,000+ enrolled participants
- Contributions to 15+ approved vaccines
CECLISA
Location: Guatemala City
Specialties: Vaccines, pediatrics, respiratory diseases, gastroenterology
Key infrastructure:
- Pediatric and adult consultation rooms
- Laboratory with sample processing and PBMC capabilities
- Procedure and observation rooms
- 70 °C freezers and validated cold chain
Completed studies:
- 20+ clinical trials
- Participation in phase II and III studies, including pediatric and COVID-19 vaccine trials
PSN
Location: Bogotá (Usaquén), Colombia
Specialties: Vaccines, gastroenterology, respiratory health
Key infrastructure:
- Private IPS with over 30 years of clinical experience
- Research center approved by INVIMA
- Electronic medical records and fast-track enrollment capability
Completed studies:
- 6+ clinical trials since 2021
- Record-setting enrollment in COVID-19 and RSV studies